Skip to content
Research Article Open access CC BY 3.0

The Effect of Co-infection of HIV and Hepatotropic Viruses on Selected Biochemical and Haematological Markers of Patients in Northeastern Nigeria

Simon O. Obi, Haruna A. Baba, Marycelin M. Baba, Grace I. Amilo, Alhaji Bukar

International Journal of TROPICAL DISEASE & Health · pp. 568–581 · Published 3 Mar 2014

10.9734/IJTDH/2014/8017

Abstract

Background: As deaths caused by HIV declines with the use of HAART, liver disease associated with co-infection of HIV with hepatotropic viruses has become an increasing cause of morbidity and mortality. Aim: To assess the effect of HIV-mono and co-infections with hepatotropic viruses on haematological and biochemical markers of the patients. Methodology: 109 HIV patients from tertiary health facilities in northeastern Nigeria were initially screened with Immuno chromatographic kit for HIV antibody and confirmed by western blot prospectively and consecutively. However, Hepatitis B virus surface antigen (HBsAg) and Hepatitis C virus (HCV) antibody were detected on the HIV positive patients by ELISA. Blood donors served as control. The study was conducted between January and October 2012. Results: Of the HIV patients 12.8% and 4.6% had HBsAg and HCV antibody respectively. The prevalence rate of Hepatitis B virus (HBV) infection among males was 12.8% while females had 12.9% but lower rates of HCV were obtained in both males (5.1%) and females (3.3%). However, HIV mono-infections had higher mean baseline values for haemogblobin (Hb), CD4 and platelet counts, protein C (PC) and protein S (PS) in comparison with HIV/ HBV/HCV co-infections (P<0.05). In addition, Prothrombin time and partial thromboplastin time were lower in HIV mono- infection in contrast to co-infections (P<0.05). Similarly, the mean values of Serum liver enzymes such as Aspartate transaminase (AST), Alanine transaminase (ALT), Akaline Phosphatase (ALP) and creatinine were lower in HIV mono-infection compared with HIV/HBV or HIV/HCV co-infection (P<0.05). Total white blood cell count (WBC), total cholesterol (TCH), Random blood sugar (RBS) and potassium (K+) were not significantly different (P>0.05) in both groups. Conclusion: Co-infections of HIV and hepatotropic viruses do occur. Haematological and biochemical parameters serve as pointers for early detection of liver disease in HIV patients. The development of novel therapeutic approaches to impede co-infection of HIV and hepatotropic viruses is encouraged.

HIV hepatitis B virus hepatitis C virus co-infection haematological and biochemical markers

References (34)

  1. 1 Evaluation of Abnormal Liver-Enzyme Results in Asymptomatic Patients [DOI]
  2. 2 Epidemiology of viral hepatitis and HIV co-infection [DOI]
  3. 3 Hepatitis C Virus Prevalence among Patients Infected with Human Immunodeficiency Virus: A Cross-Sectional Analysis of the US Adult AIDS Clinical Trials Group [DOI]
  4. 4 Human immunodeficiency virus infection modified the natural history of chronic parenterally-acquired hepatitis C with an unusually rapid progression to cirrhosis [DOI]
  5. 5 Association of Diabetes Mellitus and Chronic Hepatitis C Virus Infection [DOI]
  6. 6 Impact of human immunodeficiency virus (HIV) infection on the progression of liver fibrosis in hepatitis C virus infected patients [DOI]
  7. 7 Relationship between hepatitis C virus infection and type 2 diabetes mellitus: Meta-analysis [DOI]
  8. 8 Mortality by baseline CD4 cell count among HIV patients initiating antiretroviral therapy: evidence from a large cohort in Uganda [DOI]
  9. 9 Overt diabetes mellitus among newly diagnosed Ugandan tuberculosis patients: a cross sectional study [DOI]
  10. 10 Drug-Induced Liver Injury Associated with Antiretroviral Therapy that Includes HIV-1 Protease Inhibitors [DOI]
  11. 11 Role of molecular mimicry to HIV-1 peptides in HIV-1–related immunologic thrombocytopenia [DOI]
  12. 12 Hepatitis C Virus Infection and Human Pancreatic β-Cell Dysfunction [DOI]
  13. 13 Is chronic HIV infection associated with venous thrombotic disease? A systematic review.
  14. 14 Presence of cross-reactive antibody between human immunodeficiency virus (HIV) and platelet glycoproteins in HIV-related immune thrombocytopenic purpura [DOI]
  15. 15 Clinical profile of HIV in India.
  16. 16 Hepatitis C and HIV co-infection: A review [DOI]
  17. 17 Secondary immune thrombocytopenic purpura [DOI]
  18. 18 Haematological complications of HIV Infection [DOI]
  19. 19 Healthy range for serum ALT and the clinical significance of “unhealthy” normal ALT levels in the Korean population [DOI]
  20. 20 Hepatitis B surface antigen, hepatitis C and HIV antibodies in a low-risk blood donor group, Nigeria.
  21. 21 Upper normal threshold of serum alanine aminotransferase in identifying individuals at risk for chronic liver disease [DOI]
  22. 22 HIV and venous thrombotic events.
  23. 23 The evolution of haematological and biochemical indices in HIV patients during a six-month treatment period.
  24. 24 GPIIIa-(49–66) is a major pathophysiologically relevant antigenic determinant for anti-platelet GPIIIa of HIV-1-related immunologic thrombocytopenia [DOI]
  25. 25 Clinical outcomes of hepatitis B virus (HBV) genotypes B and C in Japanese patients with chronic HBV infection. [DOI]
  26. 26 Coinfection with hepatitis B and C viruses among HIV positive pregnant women in Enugu south east, Nigeria.
  27. 27 Biochemical and haematological changes in HIV subjects receiving winniecure antiretroviral drug in Nigeria [DOI]
  28. 28 Association of Hepatitis C Virus Infection with Type II Diabetes in Ethiopia: A Hospital-Based Case-Control Study [DOI]
  29. 29 Anti-human immunodeficiency virus type 1 antibody complexes on platelets of seropositive thrombocytopenic homosexuals and narcotic addicts. [DOI]
  30. 30 Autoimmune anti-HIV-1gp120 antibody with antiidiotype-like activity in sera and immune complexes of HIV-1-related immunologic thrombocytopenia. [DOI]
  31. 31 Alanine Aminotransferase Levels Predict Insulin Resistance in HIV Lipodystrophy [DOI]
  32. 32 Hepatitis C and HIV co-infection [DOI]
  33. 33 Immunochemical analysis of platelet autoantibodies in HIV‐related thrombocytopenic purpura: a study of 68 patients [DOI]
  34. 34 HIV and hepatitis C co-infection [DOI]

Cited by 10

Human immunodeficiency virus and hepatitis B virus (HIV/HBV) co-infection in people living with HIV/AIDs identified in Yaound Central Hospital, Cameroon: Seroprevalence and impact on the disease progression

Ngounoue Marceline Djuidje, Axel Cyriaque Ambassa, Tamo Ida Marlene Guiateu · Journal of AIDS and HIV Research · 2017

Effects of Hepatitis B Virus Co-Infection and Antiretroviral Therapy on Disease Progression among HIV Patients Treated at the Buea Regional Hospital, Southwest Region, Cameroon: A Case-Control Study

Henry Dilonga Meriki, Andinwoh Ngassa Betterdel, Kukwah Anthony Tufon · Journal of Biosciences and Medicines · 2022

Showing 2 of 10 known citations — external sources report more than can currently be individually listed.

Related research

Article metrics

Real usage data collected on this platform.

7

Page views

0

PDF downloads

1

Outbound clicks

10

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.